Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Life Edit Therapeutics

Main (gene editing) focus: Novel gene- and cell therapies

Company stage: Pre-clinical

Diseases: Undisclosed

Genome editing tool: CRISPR-Cas, base editing, CRISPRa/CRISPRi

Funding stage: Private

Location: Research Triangle Park, North Carolina, USA

Website: https://www.lifeeditinc.com/

Partners: ElevateBio

Life Edit Therapeutics was recently acquired and is now a subsidiary of ElevateBio. The company develops multiple novel gene-editing technologies, including CRISPR-Cas, base editing and CRISPRa/CRISPRi systems. The company yet has to disclose its lead programmes.

Tags

HashtagLife Edit Therapeutics

Company: Life Edit Therapeutics
close
Search CRISPR Medicine